Parkinsonian Disorders
A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
Subtype terms (3)
More specific conditions that are subtypes of Parkinsonian Disorders in the MeSH hierarchy.
- Lewy Body Disease
46 drugs (24 approved, 22 experimental)
- Parkinson Disease
539 drugs (208 approved, 331 experimental)
- Parkinson Disease, Secondary
6 drugs approved
Drugs by status
Approved for this indication (8)
Phase 4 trials (11)
Phase 3 trials (2)
Phase 2 trials (10)
Phase 1 trials (6)
Organizations
Organization Involved with Phase 4 Indications (9)
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (11)
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (4)